Blake Borgeson
Director · RECURSION PHARMACEUTICALS, INC.
IndividualSelling only14 10b5-1 trades
- 2024
- Oct 7, 2026
- 16
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Blake Borgeson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Gibson - $2.41M in RXRX purchases and sales in the last 12 months
- Najat Khan - $258K in RXRX purchases and sales in the last 12 months
- Robert Hershberg - $125K in RXRX purchases and sales in the last 12 months
- Ben R. Taylor - $68K in RXRX purchases and sales in the last 12 months
- Namandje Bumpus - $28K in RXRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Blake Borgeson?
Blake Borgeson is a corporate insider, tracked as Director of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha holds 16 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Blake Borgeson submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Blake Borgeson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 14 open-market sales ($3.69M) across all tracked filings.
